Skip to main content
logo
Ceryvyn Therapeutics Limited (ASX:CYV)
Australia flag Australia · Delayed Price · Currency is AUD
0.0130
0.00 (0.00%)
Oct 9, 2026, 4:12 PM AEST

Ceryvyn Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
1821739382257387
Market Cap Growth
-97.59%-97.22%93.39%48.68%-33.67%-17.33%
Enterprise Value
-12-13886417178266
Last Close Price
0.010.010.600.350.480.96

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
0.050.06----
Forward PE
-109.83109.83109.83109.83109.83
PS Ratio
17783.7220519.673240.23972.82443.861341.13
PB Ratio
0.600.69-2.41-3.36-29.225.56
P/TBV Ratio
0.600.69---5.56

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
--3884.011061.86307.67921.14

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
---1.23-2.65-14.67-
Net Debt / Equity Ratio
-1.01-1.01-0.99-0.370.57-0.93
Net Debt / EBITDA Ratio
2.522.52-1.25-0.150.020.46
Net Debt / FCF Ratio
2.402.40-1.24-0.170.030.63
Asset Turnover
000.000.000.010.00
Quick Ratio
13.4313.430.222.885.114.25
Current Ratio
13.7813.780.222.945.254.97
Return on Equity (ROE)
-----676.67%-101.29%
Return on Assets (ROA)
-12.59%-12.59%-80.66%-83.43%-118.18%-60.81%
Return on Capital Employed (ROCE)
-40.30%-40.30%78.80%-153.80%-187.80%-201.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
1858.13%1610.38%-33.99%-86.41%-83.34%-34.78%
FCF Yield
-70.28%-60.91%-33.13%-63.19%-70.54%-26.73%
Buyback Yield / Dilution
-10.23%-10.23%-91.90%-44.18%-25.91%-9.71%